Working… Menu

Decitabine and Talazoparib in Untreated AML and R/R AML (1565GCC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02878785
Recruitment Status : Recruiting
First Posted : August 25, 2016
Last Update Posted : July 11, 2018
Van Andel Research Institute
Information provided by (Responsible Party):
Maria Baer, University of Maryland, College Park

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2020
Estimated Study Completion Date : December 2022